AT510991A5 - Peptide für die Inhibition MyD88-abhängiger Signalwege - Google Patents

Peptide für die Inhibition MyD88-abhängiger Signalwege Download PDF

Info

Publication number
AT510991A5
AT510991A5 ATA9494/2009A AT94942009A AT510991A5 AT 510991 A5 AT510991 A5 AT 510991A5 AT 94942009 A AT94942009 A AT 94942009A AT 510991 A5 AT510991 A5 AT 510991A5
Authority
AT
Austria
Prior art keywords
myd88
inhibition
peptides
signaling pathways
dependent signaling
Prior art date
Application number
ATA9494/2009A
Other languages
English (en)
Other versions
AT510991A2 (de
Original Assignee
Kemijski Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemijski Inst filed Critical Kemijski Inst
Publication of AT510991A2 publication Critical patent/AT510991A2/de
Publication of AT510991A5 publication Critical patent/AT510991A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Hemmpeptide (inhibitorische Peptide) für die Inhibition MyD88-abhängiger Signalwege Der Bereich der Erfindung ist ein neues Hemmpeptid mit einem Segment zur Inhibition der MyD88-Aktivierung. Die Erfindung umfasst das Hemmpeptid und seine Verwendung zur Heilung von Krankheitszuständen, die mit einer übermäßigen angeborenen lmmunsystemreaktion verbunden sind.
ATA9494/2009A 2009-10-09 2009-10-09 Peptide für die Inhibition MyD88-abhängiger Signalwege AT510991A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SI2009/000046 WO2011043740A1 (en) 2009-10-09 2009-10-09 Peptides for inhibition of myd88-dependent signaling pathways

Publications (2)

Publication Number Publication Date
AT510991A2 AT510991A2 (de) 2012-08-15
AT510991A5 true AT510991A5 (de) 2015-02-15

Family

ID=41588681

Family Applications (1)

Application Number Title Priority Date Filing Date
ATA9494/2009A AT510991A5 (de) 2009-10-09 2009-10-09 Peptide für die Inhibition MyD88-abhängiger Signalwege

Country Status (2)

Country Link
AT (1) AT510991A5 (de)
WO (1) WO2011043740A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057728A1 (en) * 2002-01-10 2003-07-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel splice variant of myd88 and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057728A1 (en) * 2002-01-10 2003-07-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel splice variant of myd88 and uses thereof

Also Published As

Publication number Publication date
AT510991A2 (de) 2012-08-15
WO2011043740A1 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
SG11202010883QA (en) Perfusion bioreactor with filtration systems
SG10202007196UA (en) Intelligent time-series analytic engine
IL261079A (en) Networked LED lighting system
MA46916A (fr) Resttumorinfiltrierende lymphozyten und verfahren zur herstellung und verwendung davon
BR112017016111A2 (pt) previsão residual do componente transversal adaptável
DE102014109880A8 (de) Verfahren und Systeme für die emissionsverträgliche Verwendung von telematischen Eingangsgrößen bei einem Antriebssteuerungssystem zur Funktionsumsetzung
IL252338A0 (en) Automatic lighting system of the transverse marking for crossing crossings
ATE476666T1 (de) Verfahren zur identifizierung von glykoformspezifischen antikörpern
DE112016003602A5 (de) Optoelektronisches Bauelement umfassend ein Konversionselement, Verfahren zur Herstellung eines optoelektronischen Bauelements umfassend ein Konversionselement und Verwendung eines optoelektronischen Bauelements umfassend ein Konversionselement
EP3776120A4 (de) Überwachungssystem mit multidrop-backplane-planer
SG11202010896XA (en) Led backlight
DE112014006075T8 (de) Transformierte Pflanze und Verfahren zur Herstellung von zuckerhaltigem Exsudat unter Verwendung der transformierten Pflanze
DK3590311T3 (da) Fremgangsmåde og system til at styre tændingen af lys
AT510991A5 (de) Peptide für die Inhibition MyD88-abhängiger Signalwege
DE102017001416A8 (de) Vorrichtung zur Erzeugung von Pellets
MX364417B (es) Sistemas de techado compuesto y métodos de instalación.
DK3972389T3 (da) Belysningssystem
GB2605923B (en) Water flow management system
DE112019000190A5 (de) Telekamera für ein Fahrzeug sowie Befestigung einer Telekamera am Fahrzeug
EP4055997C0 (de) Konfigurieren einer brücke mit gruppen nach dem hinzufügen der brücke zu einem beleuchtungssystem
DE112018003953A5 (de) Vorrichtung zur Herstellung von synthetischen Fäden
DE112020004362A5 (de) System mit zumindest einem Gleichrichter
DE112019005590A5 (de) Verfahren zur Herstellung wenigstens einer Nasenauflage einer Blickerfassungsbrille
DK3566284T3 (da) Energihåndtering baseret på adskillige signaler
EP3776352C0 (de) Rissbewertung von dachbahnen durch künstliche neuronale netze

Legal Events

Date Code Title Description
REJ Rejection

Effective date: 20160515